{"organizations": [], "uuid": "2dafede4bd87e289d3e5695d34ad817de481bbff", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-abbvie-receives-positive-recommend/brief-abbvie-receives-positive-recommendation-from-canadian-drug-committee-for-maviret-idUSFWN1PW0OH", "country": "US", "domain_rank": 408, "title": "BRIEF-AbbVie Receives Positive Recommendation From Canadian Drug Committee For Maviret", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-02-06T16:08:00.000+02:00", "replies_count": 0, "uuid": "2dafede4bd87e289d3e5695d34ad817de481bbff"}, "author": "", "url": "https://www.reuters.com/article/brief-abbvie-receives-positive-recommend/brief-abbvie-receives-positive-recommendation-from-canadian-drug-committee-for-maviret-idUSFWN1PW0OH", "ord_in_thread": 0, "title": "BRIEF-AbbVie Receives Positive Recommendation From Canadian Drug Committee For Maviret", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "brief-abbvie receives positive recommendation from canadian drug committee for maviret", "sentiment": "negative"}, {"name": "brief-abbvie receives positive recommendation from canadian drug committee for maviret r", "sentiment": "negative"}, {"name": "abbvie inc", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "  6 minutes BRIEF-AbbVie Receives Positive Recommendation From Canadian Drug Committee For Maviret Reuters Staff 1 Min Read \nFeb 6 (Reuters) - AbbVie Inc: \n* ABBVIE RECEIVES A POSITIVE RECOMMENDATION FROM THE CADTH CANADIAN DRUG EXPERT COMMITTEE FOR MAVIRETâ„¢ - AN ORAL THERAPY FOR THE TREATMENT OF PATIENTS WITH HEPATITIS C  ", "external_links": [], "published": "2018-02-06T16:08:00.000+02:00", "crawled": "2018-02-06T16:22:25.013+02:00", "highlightTitle": ""}